MedTrace Logo

Construction and Application of Database of Hebei Provincial Gastric Cancer Collaborative Network Driven by Artificial Intelligence Technology

NCT06506825 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30000

Last updated 2024-07-18

No results posted yet for this study

Summary

This clinical trial aims to construct and apply a collaborative network database for gastric cancer in Hebei Province, driven by artificial intelligence (AI) technology. The project seeks to integrate clinical data, genomic information, and treatment outcomes from multiple hospitals and research centers within the region. By leveraging advanced AI algorithms, the database will facilitate comprehensive data analysis to identify novel biomarkers, optimize therapeutic strategies, and improve patient outcomes. This initiative will also support real-time data sharing and collaboration among healthcare providers, researchers, and policymakers, ultimately enhancing the overall management and treatment of gastric cancer in Hebei Province.

Conditions

  • The Study Focuses on Gastric Cancer

Interventions

DIAGNOSTIC_TEST

Gastric Cancer AI-driven Data Integration Genomic Analysis Biomarker

Enter the clinical and related test, examination and treatment information of all gastric cancer patients, and find risk factors that affect the prognosis

Sponsors & Collaborators

  • Qun Zhao

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06506825 on ClinicalTrials.gov